COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01729663
Recruitment Status : Unknown
Verified August 2015 by José Mordoh, Laboratorio Pablo Cassará S.R.L..
Recruitment status was:  Recruiting
First Posted : November 20, 2012
Last Update Posted : September 2, 2015
Fundacion Sales
National Agency for Scientific and Technological Promotion, Argentina
Fundacion Cancer FUCA
National Council of Scientific and Technical Research, Argentina
Instituto Nacional del Cáncer, Argentina
Information provided by (Responsible Party):
José Mordoh, Laboratorio Pablo Cassará S.R.L.